Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Gastrointestinal Endoscopy|February 18, 2021
Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approachAnsgar Deibel, Lu Deng, Chih-Yuan Cheng, et al.Inflammatory Bowel Diseases|June 7, 2021
Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel DiseaseSebastian Bruno Ulrich Jordi, Brian Matthew Lang, Bianca Auschra, et al.Alimentary Pharmacology & Therapeutics|May 11, 2021
Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel diseaseSebastian Bruno Ulrich Jordi, Federica Botte, Brian Matthew Lang, et al.Journal of Gastroenterology|July 28, 2022
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patientsSebastian Bruno Ulrich Jordi, Brian Matthew Lang, Jacqueline Wyss, et al.Therapeutic Advances in Gastroenterology|August 11, 2023
Because I'm happy - positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort studyBrian M Lang, Martina Ledergerber, Sebastian Bruno Ulrich Jordi, et al.The Journal of Experimental Medicine|July 28, 2017
Intestinal epithelial cell endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammationShuhei Hosomi, Joep Grootjans, Markus Tschurtschenthaler, et al.BMC Gastroenterology|February 6, 2021
Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical managementMartina Ledergerber, Brian M Lang, Henriette Heinrich, et al.Therapeutic Advances in Gastroenterology|February 14, 2022
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in SwitzerlandKathrin Perrig, Niklas Krupka, Sebastian Bruno Ulrich Jordi, et al.Alimentary Pharmacology & Therapeutics|October 29, 2022
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2Simon Woelfel, Joel Dütschler, Marius König, et al.Alimentary Pharmacology & Therapeutics|October 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.Pageof 3